Comparative study of the effect of labetalol and remifentanil on pain control after bariatric surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190929044924N3

Enrollment

Registered

2022-02-05

Start date

2022-03-21

Completion date

Unknown

Last updated

2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain.

Interventions

Intervention 1: Intervention group: Lactalol group: In labetalol group, 5 mg / ml of labetalol will be injected to patients before surgical incision. Intervention 2: Intervention group: Remifentanil g

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) class I-II-III No contraindications and allergies to remifentanil or labetalol

Exclusion criteria

Exclusion criteria: Patients with cardiac arrhythmias Pregnant or Breastfeeding women People with a history of alcohol or drug use in the last 3 months

Design outcomes

Primary

Measure	Time frame
Pain severity. Timepoint: Upon entering recovery, 2, 4, 6 and 12 hours after surgery. Method of measurement: Verbal Ranking Scale (VRS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Farahmandrad

Iran University of Medical Sciences

farahmandrad.r@iums.ac.ir+98 21 6435 2326

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026